CS Paper Radar

FLARE: A Systematic, Uncertainty-Aware Framework for Evidence-Based Adoption of Artificial Intelligence in Healthcare

Jacob Idoko, Siddhartha Paudel, Mariana Bento, Roberto Souza, Gouri Ginde

cs.AI ·submitted 2026-08-24 07:12 UTC · v1

Abstract

Artificial intelligence is increasingly being introduced into healthcare workflows, yet most evaluations emphasize model accuracy rather than whether adoption is economically worthwhile in real clinical settings. This study proposes FLARE, a systematic and uncertainty-aware framework for evaluating the financial and operational implications of adopting AI in healthcare. FLARE combines fuzzy logic, time-driven activity-based costing, and return on investment analysis to estimate the cost of clinical service delivery, the cost of AI development and operation, and the economic consequences of workflow integration under uncertainty. The framework was demonstrated through an early health technology assessment case study of AI-assisted large vessel occlusion detection in the CT stroke pathway for acute ischemic stroke. The case study shows how FLARE can quantify conventional pathway cost, AI-related development and recurring costs, and AI-enabled service savings within a unified activity-based model. Under expected assumptions, the analysis identified a break-even threshold of approximately 3,992 patients per year, with positive first-year return on investment at typical annual stroke volumes of about 5,000 patients. The results further show that economic benefit depends not only on algorithmic performance, but also on patient volume, verification time, infrastructure choices, and workflow design. FLARE provides a transparent and practical decision-support framework for early-stage evaluation of AI adoption in healthcare. By making uncertainty, resource use, and implementation trade-offs explicit, it helps clinicians, administrators, and policymakers determine when AI deployment is economically viable and where operational changes may improve value.

Closest papers

Nearest neighbours by meaning across the whole index.

A Sociotechnical Review of Algorithms in Health Systems: Technical, Cost, and Human-Centered Considerations

cs.HC ·2026-09-18 ·Victoria Chui, Kelly McConvey, Shion Guha
similarity 0.63
Abstract

Artificial intelligence (AI) applications in healthcare are becoming increasingly prevalent, to assist health systems, providers, and patients with tasks such as decision-making, risk prediction, and diagnosis. This increasing computational potential brings AI applications to the forefront of workplace decision making, often without full consideration of subsequent computational, organizational, and social costs. These applications are leveraged to reduce healthcare costs and increase efficiency of daily tasks, with model-related costs being considered at varying levels of granularity. To understand these trends, we critically analyze 114 papers to examine how cost-aware AI models have been developed for health systems. We explore the data, method, and outcome choices of these models, as well as their intersection with cost and human-centered concerns, highlighting the gaps in rigorous sociotechnical model design. From these trends, we define model costs and subsequent dimensions, presenting insight into those studies reporting financial, computational, organizational and/or social measures. Further, we critique the benefits and challenges of evaluating model-related costs and sustainability concerns when developing AI models for health systems.

0.23

A Data-Driven Framework for Identifying and Prioritizing RPA Opportunities in Healthcare Processes

cs.AI cs.CL ·2026-09-08 ·Maria Alejandra Gomez, Juan Manuel Castillo
code/data similarity 0.61
Abstract · 21 pages, 2 figures, 14 tables

Robotic Process Automation (RPA) is widely used to reduce administrative burden in United States hospitals, yet an estimated 30-50% of RPA initiatives underperform because processes are selected informally, without a repeatable method to catalogue candidates, prioritize them, match each to an automation tier -- a Python bot, an open-source orchestrator such as n8n, or an enterprise platform such as UiPath -- and forecast financial return before committing resources. We propose a four-module, data-driven framework unifying these decisions: a Process Taxonomy of twenty recurring hospital processes across five value streams; a Prioritization module deriving an Automation Suitability Index from an Analytic Hierarchy Process matrix with an explicit consistency check; a Tool-Tier Selection module recommending the least-cost technology sufficient for a process complexity, integration, and compliance profile; and a Return-on-Investment module quantifying labor savings, error-cost avoidance, payback, and net present value. Applied to a synthetic portfolio spanning all twenty processes, plus a reference data-flow architecture linking it to hospital EHR/payer/ERP systems: 12 of 20 clear the prioritization threshold; the ranking is robust to +/-20% weight perturbation (Spearman correlation 0.83, top-5 set preserved 97.7%, 2,000 Monte Carlo trials); an Automation Risk Index flags four qualifying processes as Critical risk; a budget-constrained portfolio optimization shows diminishing marginal NPV as spend scales from $400K to $1.03M; and a second Monte Carlo analysis shows portfolio NPV stays positive at its 5th percentile. The framework is a conceptual synthesis of the literature rather than an instrument calibrated on primary hospital data; we discuss HIPAA governance and a research agenda for empirical validation. A supplementary Python implementation accompanies the paper.

0.39

AI Model Design and Physician Liability

cs.AI econ.TH ·2026-08-12 ·Shujie Luan, Shubhranshu Singh, Tinglong Dai
similarity 0.59
Abstract · Forthcoming in Management Science. 66 pages, 8 figures, 5 tables; includes online appendix (pp. oa1-oa15)

Clinical algorithms can perform differently across patient groups, a concern that grows as these algorithms increasingly take the form of artificial intelligence (AI) models. In the United States, a 2024 federal rule bars healthcare providers that receive federal funds from discriminating through their use of clinical algorithms, which exposes them to liability when such use disadvantages a protected patient group. We examine how such liability considerations reshape (i) an AI firm's model design decisions that drive group-specific accuracy and (ii) a physician's decisions to use AI in healthcare delivery. The firm designs an AI model for two patient groups, and improving accuracy for the disadvantaged group is more costly. The physician (who remains the accountable decision maker) then decides whether to consult AI, weighing the reduction in clinical uncertainty against expected liability exposure when AI errors disproportionately affect the disadvantaged group. We find that this liability can induce disparate use of AI: the physician may reduce AI use overall and, over an intermediate range of liability, rely on AI less for disadvantaged patients. The effect is non-monotone. As liability increases, the physician's use of AI for disadvantaged patients first declines, then rises as the firm reallocates investment toward reducing disparity or switches to an equal-accuracy design. Mandating equal algorithmic accuracy across patient groups can then inadvertently harm both groups, because a uniform accuracy requirement distorts the firm's investment incentives and the physician's equilibrium AI-use decisions.

0.10

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

cs.AI cs.HC ·2026-08-31 ·Paulius Mui, Dean F. Sittig, Steve Labkoff, Sanjay Basu
similarity 0.58
Abstract

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

0.13

Verify, Offload, Extend & Recommend: Selective Complementarity in AI Support for Physical Activity Planning with Longitudinal Patient Data

cs.HC ·2026-09-16 ·Pavithren V S Pakianathan, Rania Islambouli, Diogo Branco, Gil Batista Rosa, Rita Pinto +3 more
similarity 0.57
Abstract

Self-tracking technologies create longitudinal patient-generated health data, yet integrating these data into clinical decision-making can increase information-processing demands. Generative AI may support sensemaking, but its value depends on clinical context and expertise. We investigate AI augmentation of a clinical decision support system for physical-activity planning in cardiovascular disease. In a counterbalanced within-subjects study, 26 exercise physiologists developed plans for four real cardiovascular cases with and without AI support, followed by evaluation of an AI exercise-plan generator. AI did not significantly improve workload, usability, confidence, or plan quality overall; however, its effect on plan quality increased as visualization literacy decreased and its effect on workload increased as visualisation literacy increased. Interviews and 152 chatbot queries revealed three recurring uses: verifying, offloading, extend and generate. Our findings position AI support as a selective complement to professional expertise while highlighting validation challenges when clinicians seek support precisely where their own knowledge is limited.

0.29

CareGraph: An Auditable Hybrid AI Framework for Evidence-Grounded Personalized Longitudinal Health Intelligence

cs.AI cs.IRcs.MA ·2026-08-25 ·Pratik Ghawate, Tanvi Patil
benchmarkcode/data similarity 0.57
Abstract · 21 pages, 7 figures, Code and data: https://github.com/PratikGhawate/ai-personalized-health-intelligence

Artificial intelligence is transforming personalized healthcare, yet fragmented clinical, self reported, and wearable evidence remains difficult to interpret and trace. We present CareGraph, an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations. CareGraph organizes evidence without diagnosing, predicting outcomes, selecting treatment, or making autonomous clinical decisions. Its pipeline covers deterministic analysis, context detection, graph construction, constrained language model synthesis, evidence validation, safety controls, and release gating. Tests used synthetic cohorts of 400 patients each for development, validation, and holdout. On holdout data, a frozen ordinary least squares trend rule with a sufficiency gate achieved 0.827 accuracy, 0.837 macro F1 with a 95 percent confidence interval of 0.819 to 0.854, and 0.974 insufficient data F1. Missing context detection achieved 0.815 strict micro F1 versus 0.318 for the legacy detector. On an authored holdout benchmark, safety ruleset version 1.2 achieved 1.000 precision, 0.950 recall, and 0.974 F1. An audit requiring graph retrieval across 80 patients yielded 79 syntheses and 78 presentations without fallback; one output was blocked and one failed closed because of an invalid evidence key. Against monolithic GPT 5.6 on 56 matched patients, CareGraph was faster at 40.15 versus 49.62 seconds, shorter at 661 versus 1,163 words, and showed better exploratory lexical alignment with longitudinal targets; the baseline used fewer tokens and cited more raw evidence. Graph auditing verified provenance and deterministic retrieval; incremental graph effects on generation require paired evaluation. CareGraph offers a safety bounded foundation for intelligent personalized health systems.

0.42

Clinical predictions using artificial intelligence in neurosurgery and its subspecialties: a systematic review and meta-analysis

cs.AI q-bio.TO ·2026-11-09 ·Prajwal Ghimire, Aswin Chari, Jonathan Shapey, Keyoumars Ashkan
publishedsurvey similarity 0.57
Abstract

Artificial intelligence models for clinical prediction are proliferating across neurosurgery, but their aggregate discriminative performance, distribution along the care pathway and methodological quality are unclear. We systematically reviewed and meta-analysed these studies in neurosurgery and its subspecialities along with their risk of bias appraisal. We performed a PRISMA search for peer-reviewed original studies using AI to predict a clinical outcome in neurosurgical populations. Metrics were pooled using random effects modelling. Each study was classified as diagnostic, prognostic or forecasting and was assigned an evidence level. Clinical prediction task sub-stratification analysis was performed. Risk-of-bias was assessed using PROBAST. 1063 studies were included. Across 451 studies reporting AUC, pooled discrimination was 0.86, ranging from 0.84 (spine) to 0.87 (neuro-oncology), with extreme heterogeneity. Performance varied by clinical pathway stage, highest for diagnosis, grading and molecular tasks and lowest for post-operative tasks. Only 51 studies were using prospective data with external validation, whereas 619 rested on internal validation alone or no validation. 89 percent studies were at high risk-of-bias, driven by the analysis domain. AI models report high performance across all the neurosurgical subspecialities, concordant across AUC, accuracy, sensitivity and specificity and robust to risk-of-bias stratification. Performance is highest for imaging-anchored diagnostic tasks and lowest at decision-facing post-operative stage. However, the literature is dominated by optimism-prone, internally-validated and poorly calibrated models with extreme heterogeneity. External validation, calibration analysis and reporting guidelines adherence remain prerequisites for clinical adoption.

0.35

Fairness or Fallacy? Mapping the Landscape of AI Bias in Disease Detection

cs.AI ·2026-10-19 ·Ghulam Mudassir, Hameed Ullah Khan, Ahmad Sami Al-Shamayleh, Muhammad Faizan Khan, Muhammad Muqtasid +2 more
similarity 0.56
Abstract

Artificial intelligence (AI) has several transformative effects on healthcare, like to facilitate clinicians in disease detection and to manage patient care with enhanced precision. Due to the increasing complexity of medical data and the growing volume of diagnostic images, the substantial computational power needed to process such information creates both opportunities and challenges. To accomplish this objective, numerous methodologies have been proposed to integrate AI into disease detection systems. All these methodologies consider different aspects of clinical diagnosis, considering key parameters such as the type of AI model employed, the nature of input data, and the population demographics being analysed. In this paper, we review different state-of-the-art techniques which have been proposed for various areas of disease detection, specifically focusing on bias identification and mitigation. The proposed solutions are distinguished based on the type of input data they utilize, the architecture of model, and type of bias (algorithmic bias, demographic bias, model bias, and deployment bias). The time frame chosen to filter out relevant studies is between 2015 and 2026. Eventually, we review 23 related articles out of 64,389 analyzed from seven different digital libraries. The obtained results guide us to reach a conclusion with respect to state-of-the-art selected studies. Furthermore, these results reveal significant research gaps that can assist researchers in addressing AI-related bias in medical diagnosis. By prioritizing explainability, data diversity, and fairness in algorithmic design, as well as equitable access for affected patient populations, they can utilize available healthcare resources more effectively.

0.32